Share Price and Basic Stock Data
Last Updated: January 21, 2026, 7:23 pm
| PEG Ratio | 0.90 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bharat Seats Ltd operates in the automotive ancillary industry, specializing in manufacturing seats and other components for automobiles. The company’s revenue trajectory has shown resilience, with reported sales rising from ₹818 Cr in FY 2022 to ₹1,051 Cr in FY 2023, and further to ₹1,067 Cr in FY 2024. The trailing twelve months (TTM) revenue stood at ₹1,585 Cr, indicating a robust growth pattern. Quarterly sales figures have also been promising, with the most recent quarter (Sep 2023) reporting sales of ₹285.98 Cr, a slight decline from ₹293.43 Cr in Mar 2023 but reflecting a recovery from the ₹252.75 Cr in Jun 2023. The company appears to be navigating market fluctuations effectively, suggesting a steady demand for its products amidst industry challenges.
Profitability and Efficiency Metrics
Bharat Seats Ltd’s profitability metrics indicate a solid operational performance. The operating profit margin (OPM) recorded a steady improvement, rising from 4.10% in Sep 2022 to 5.92% in Sep 2023. The net profit also reflected this trend, with the most recent net profit reported at ₹6.79 Cr for Sep 2023, up from ₹4.67 Cr in Jun 2023. The company’s return on equity (ROE) stood at 18.0%, and return on capital employed (ROCE) was 15.6%, both of which are competitive against industry benchmarks. The interest coverage ratio (ICR) of 8.87x indicates a strong ability to meet interest obligations, while the cash conversion cycle (CCC) of -13 days highlights efficiency in managing working capital.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bharat Seats Ltd reflects a robust financial position, with total assets reported at ₹693 Cr as of Sep 2025, an increase from ₹648 Cr in Mar 2025. The company’s borrowings amounted to ₹132 Cr, against reserves of ₹194 Cr, suggesting a healthy equity base relative to debt. Key financial ratios indicate stability, with a price-to-book value (P/BV) ratio of 2.48x, which is reasonable for the sector. The current ratio stood at 0.79, indicating potential liquidity concerns, although it remains manageable within the context of the company’s operational cash flows. The total debt-to-equity ratio of 0.41x suggests a conservative leverage position, while the dividend payout ratio of 15.36% reflects a commitment to returning value to shareholders.
Shareholding Pattern and Investor Confidence
The shareholding structure of Bharat Seats Ltd indicates a strong promoter backing, with promoters holding 74.66% of the equity as of Mar 2025. This high level of promoter ownership often correlates with investor confidence, as it suggests alignment of interests between management and shareholders. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold minimal stakes of 0.27% and 0.12%, respectively, indicating limited interest from institutional investors. However, the public shareholding remains at 24.95%, with the number of shareholders increasing to 26,898, suggesting growing retail investor interest. This could enhance liquidity and market visibility, but the low institutional participation may limit large-scale investment inflows.
Outlook, Risks, and Final Insight
Moving forward, Bharat Seats Ltd appears well-positioned to capitalize on the growing automotive sector, driven by rising consumer demand and potential expansions in product offerings. However, risks such as fluctuating raw material prices and supply chain disruptions could impact profitability. Additionally, increasing competition within the automotive ancillary space may pressure margins. The company’s strong financial metrics, including a solid ROE and manageable debt levels, provide a cushion against these risks. If Bharat Seats can maintain its growth trajectory while effectively managing operational efficiencies, it may enhance shareholder value significantly in the coming years. Conversely, failure to adapt to market dynamics could hinder its performance, necessitating close monitoring of industry trends and internal operational strategies.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| G S Auto International Ltd | 42.6 Cr. | 29.4 | 44.1/29.1 | 23.2 | 16.8 | 0.00 % | 12.2 % | 6.32 % | 5.00 |
| Duncan Engineering Ltd | 155 Cr. | 420 | 565/277 | 33.8 | 158 | 0.71 % | 13.2 % | 9.53 % | 10.0 |
| Divgi Torqtransfer Systems Ltd | 1,794 Cr. | 585 | 705/410 | 59.3 | 199 | 0.44 % | 5.69 % | 4.14 % | 5.00 |
| Bharat Seats Ltd | 900 Cr. | 143 | 240/61.1 | 23.6 | 32.9 | 0.77 % | 15.6 % | 18.0 % | 2.00 |
| Automobile Corporation of Goa Ltd | 1,078 Cr. | 1,770 | 2,349/936 | 15.9 | 458 | 1.41 % | 20.2 % | 19.7 % | 10.0 |
| Industry Average | 5,077.62 Cr | 590.04 | 37.79 | 154.70 | 0.75% | 15.11% | 122.81% | 5.59 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 290.75 | 219.18 | 293.43 | 252.75 | 285.98 | 249.98 | 278.10 | 298.85 | 290.67 | 306.39 | 392.91 | 427.06 | 458.60 |
| Expenses | 278.82 | 209.03 | 278.77 | 240.66 | 269.04 | 235.33 | 260.98 | 282.34 | 273.01 | 287.81 | 370.20 | 405.35 | 435.95 |
| Operating Profit | 11.93 | 10.15 | 14.66 | 12.09 | 16.94 | 14.65 | 17.12 | 16.51 | 17.66 | 18.58 | 22.71 | 21.71 | 22.65 |
| OPM % | 4.10% | 4.63% | 5.00% | 4.78% | 5.92% | 5.86% | 6.16% | 5.52% | 6.08% | 6.06% | 5.78% | 5.08% | 4.94% |
| Other Income | 0.97 | 1.44 | 1.35 | 1.09 | 0.84 | 1.45 | 1.16 | 0.95 | 0.70 | 0.65 | 1.28 | 1.07 | 2.69 |
| Interest | 0.83 | 0.91 | 1.18 | 1.38 | 2.38 | 2.24 | 1.75 | 2.23 | 2.27 | 2.31 | 2.10 | 2.50 | 2.99 |
| Depreciation | 4.21 | 4.21 | 4.32 | 5.41 | 6.30 | 6.29 | 6.01 | 6.35 | 6.50 | 6.64 | 6.76 | 7.94 | 9.06 |
| Profit before tax | 7.86 | 6.47 | 10.51 | 6.39 | 9.10 | 7.57 | 10.52 | 8.88 | 9.59 | 10.28 | 15.13 | 12.34 | 13.29 |
| Tax % | 25.32% | 26.74% | 29.88% | 26.92% | 25.49% | 27.08% | 23.29% | 25.56% | 25.96% | 26.17% | 24.72% | 25.69% | 25.51% |
| Net Profit | 5.87 | 4.75 | 7.37 | 4.67 | 6.79 | 5.52 | 8.08 | 6.61 | 7.10 | 7.59 | 11.39 | 9.18 | 9.90 |
| EPS in Rs | 0.93 | 0.76 | 1.17 | 0.74 | 1.08 | 0.88 | 1.29 | 1.05 | 1.13 | 1.21 | 1.81 | 1.46 | 1.58 |
Last Updated: December 27, 2025, 7:37 pm
Below is a detailed analysis of the quarterly data for Bharat Seats Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 458.60 Cr.. The value appears strong and on an upward trend. It has increased from 427.06 Cr. (Jun 2025) to 458.60 Cr., marking an increase of 31.54 Cr..
- For Expenses, as of Sep 2025, the value is 435.95 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 405.35 Cr. (Jun 2025) to 435.95 Cr., marking an increase of 30.60 Cr..
- For Operating Profit, as of Sep 2025, the value is 22.65 Cr.. The value appears strong and on an upward trend. It has increased from 21.71 Cr. (Jun 2025) to 22.65 Cr., marking an increase of 0.94 Cr..
- For OPM %, as of Sep 2025, the value is 4.94%. The value appears to be declining and may need further review. It has decreased from 5.08% (Jun 2025) to 4.94%, marking a decrease of 0.14%.
- For Other Income, as of Sep 2025, the value is 2.69 Cr.. The value appears strong and on an upward trend. It has increased from 1.07 Cr. (Jun 2025) to 2.69 Cr., marking an increase of 1.62 Cr..
- For Interest, as of Sep 2025, the value is 2.99 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.50 Cr. (Jun 2025) to 2.99 Cr., marking an increase of 0.49 Cr..
- For Depreciation, as of Sep 2025, the value is 9.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.94 Cr. (Jun 2025) to 9.06 Cr., marking an increase of 1.12 Cr..
- For Profit before tax, as of Sep 2025, the value is 13.29 Cr.. The value appears strong and on an upward trend. It has increased from 12.34 Cr. (Jun 2025) to 13.29 Cr., marking an increase of 0.95 Cr..
- For Tax %, as of Sep 2025, the value is 25.51%. The value appears to be improving (decreasing) as expected. It has decreased from 25.69% (Jun 2025) to 25.51%, marking a decrease of 0.18%.
- For Net Profit, as of Sep 2025, the value is 9.90 Cr.. The value appears strong and on an upward trend. It has increased from 9.18 Cr. (Jun 2025) to 9.90 Cr., marking an increase of 0.72 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.58. The value appears strong and on an upward trend. It has increased from 1.46 (Jun 2025) to 1.58, marking an increase of 0.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:04 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 560 | 693 | 700 | 840 | 970 | 904 | 589 | 548 | 818 | 1,051 | 1,067 | 1,289 | 1,585 |
| Expenses | 531 | 661 | 670 | 803 | 905 | 853 | 553 | 521 | 785 | 1,005 | 1,006 | 1,213 | 1,499 |
| Operating Profit | 29 | 32 | 30 | 37 | 65 | 50 | 36 | 27 | 32 | 46 | 61 | 75 | 86 |
| OPM % | 5% | 5% | 4% | 4% | 7% | 6% | 6% | 5% | 4% | 4% | 6% | 6% | 5% |
| Other Income | 0 | 2 | 2 | 1 | 1 | 5 | 2 | 2 | 5 | 4 | 5 | 4 | 6 |
| Interest | 6 | 6 | 5 | 4 | 3 | 3 | 3 | 4 | 4 | 4 | 8 | 9 | 10 |
| Depreciation | 14 | 16 | 17 | 17 | 19 | 21 | 22 | 18 | 18 | 17 | 24 | 26 | 30 |
| Profit before tax | 9 | 11 | 10 | 17 | 44 | 31 | 12 | 7 | 16 | 30 | 34 | 44 | 51 |
| Tax % | 26% | 29% | 27% | 28% | 35% | 31% | -2% | 28% | 25% | 27% | 25% | 26% | |
| Net Profit | 7 | 8 | 7 | 12 | 28 | 21 | 13 | 5 | 12 | 22 | 25 | 33 | 38 |
| EPS in Rs | 1.07 | 1.29 | 1.15 | 1.94 | 4.49 | 3.41 | 1.99 | 0.77 | 1.90 | 3.43 | 3.99 | 5.21 | 6.06 |
| Dividend Payout % | 37% | 35% | 39% | 23% | 11% | 15% | 13% | 33% | 21% | 20% | 20% | 21% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 14.29% | -12.50% | 71.43% | 133.33% | -25.00% | -38.10% | -61.54% | 140.00% | 83.33% | 13.64% | 32.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -26.79% | 83.93% | 61.90% | -158.33% | -13.10% | -23.44% | 201.54% | -56.67% | -69.70% | 18.36% |
Bharat Seats Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 17% |
| 3 Years: | 16% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 21% |
| 3 Years: | 40% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 37% |
| 3 Years: | 60% |
| 1 Year: | 46% |
| Return on Equity | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 13% |
| 3 Years: | 17% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 2:41 pm
Balance Sheet
Last Updated: December 4, 2025, 2:31 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 13 | 13 |
| Reserves | 35 | 40 | 47 | 56 | 80 | 98 | 107 | 110 | 121 | 140 | 161 | 182 | 194 |
| Borrowings | 102 | 91 | 75 | 63 | 25 | 29 | 40 | 35 | 39 | 66 | 160 | 152 | 132 |
| Other Liabilities | 109 | 127 | 122 | 140 | 172 | 140 | 89 | 140 | 171 | 146 | 179 | 301 | 354 |
| Total Liabilities | 253 | 265 | 250 | 265 | 285 | 273 | 242 | 291 | 337 | 358 | 505 | 648 | 693 |
| Fixed Assets | 150 | 150 | 144 | 146 | 136 | 152 | 150 | 126 | 147 | 199 | 276 | 283 | 367 |
| CWIP | 4 | 3 | 1 | 0 | 13 | 0 | 22 | 30 | 8 | 12 | 49 | 90 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 99 | 111 | 104 | 119 | 135 | 121 | 69 | 135 | 182 | 147 | 181 | 275 | 320 |
| Total Assets | 253 | 265 | 250 | 265 | 285 | 273 | 242 | 291 | 337 | 358 | 505 | 648 | 693 |
Below is a detailed analysis of the balance sheet data for Bharat Seats Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
- For Reserves, as of Sep 2025, the value is 194.00 Cr.. The value appears strong and on an upward trend. It has increased from 182.00 Cr. (Mar 2025) to 194.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 132.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 152.00 Cr. (Mar 2025) to 132.00 Cr., marking a decrease of 20.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 354.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 301.00 Cr. (Mar 2025) to 354.00 Cr., marking an increase of 53.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 693.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 648.00 Cr. (Mar 2025) to 693.00 Cr., marking an increase of 45.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 367.00 Cr.. The value appears strong and on an upward trend. It has increased from 283.00 Cr. (Mar 2025) to 367.00 Cr., marking an increase of 84.00 Cr..
- For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 90.00 Cr. (Mar 2025) to 6.00 Cr., marking a decrease of 84.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 320.00 Cr.. The value appears strong and on an upward trend. It has increased from 275.00 Cr. (Mar 2025) to 320.00 Cr., marking an increase of 45.00 Cr..
- For Total Assets, as of Sep 2025, the value is 693.00 Cr.. The value appears strong and on an upward trend. It has increased from 648.00 Cr. (Mar 2025) to 693.00 Cr., marking an increase of 45.00 Cr..
Notably, the Reserves (194.00 Cr.) exceed the Borrowings (132.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -73.00 | -59.00 | -45.00 | -26.00 | 40.00 | 21.00 | -4.00 | -8.00 | -7.00 | -20.00 | -99.00 | -77.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 40 | 43 | 41 | 35 | 31 | 22 | 55 | 49 | 34 | 35 | 56 |
| Inventory Days | 8 | 7 | 9 | 8 | 12 | 11 | 16 | 24 | 28 | 12 | 16 | 19 |
| Days Payable | 59 | 56 | 60 | 61 | 66 | 59 | 57 | 99 | 68 | 48 | 59 | 87 |
| Cash Conversion Cycle | -8 | -8 | -8 | -13 | -19 | -17 | -19 | -20 | 9 | -3 | -7 | -13 |
| Working Capital Days | -38 | -35 | -34 | -26 | -13 | -12 | -18 | -13 | 2 | -13 | -17 | -20 |
| ROCE % | 11% | 13% | 12% | 17% | 40% | 28% | 11% | 7% | 12% | 18% | 15% | 16% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 5.21 | 7.98 | 6.86 | 3.79 | 1.53 |
| Diluted EPS (Rs.) | 5.21 | 7.98 | 6.86 | 3.79 | 1.53 |
| Cash EPS (Rs.) | 9.39 | 15.62 | 12.30 | 9.40 | 7.26 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 30.98 | 53.13 | 46.60 | 40.49 | 37.14 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 30.98 | 53.13 | 46.60 | 40.49 | 37.14 |
| Dividend / Share (Rs.) | 1.10 | 1.60 | 1.40 | 0.80 | 0.50 |
| Revenue From Operations / Share (Rs.) | 205.23 | 339.75 | 334.73 | 260.39 | 174.41 |
| PBDIT / Share (Rs.) | 12.59 | 20.80 | 16.03 | 11.92 | 9.20 |
| PBIT / Share (Rs.) | 8.41 | 13.16 | 10.59 | 6.31 | 3.48 |
| PBT / Share (Rs.) | 6.99 | 10.69 | 9.44 | 5.07 | 2.12 |
| Net Profit / Share (Rs.) | 5.21 | 7.98 | 6.86 | 3.79 | 1.53 |
| PBDIT Margin (%) | 6.13 | 6.12 | 4.78 | 4.57 | 5.27 |
| PBIT Margin (%) | 4.09 | 3.87 | 3.16 | 2.42 | 1.99 |
| PBT Margin (%) | 3.40 | 3.14 | 2.81 | 1.94 | 1.21 |
| Net Profit Margin (%) | 2.53 | 2.34 | 2.05 | 1.45 | 0.87 |
| Return on Networth / Equity (%) | 16.80 | 15.01 | 14.72 | 9.37 | 4.12 |
| Return on Capital Employeed (%) | 16.54 | 14.13 | 17.42 | 11.75 | 7.26 |
| Return On Assets (%) | 5.04 | 4.95 | 6.02 | 3.53 | 1.64 |
| Long Term Debt / Equity (X) | 0.25 | 0.31 | 0.22 | 0.25 | 0.21 |
| Total Debt / Equity (X) | 0.41 | 0.52 | 0.40 | 0.29 | 0.25 |
| Asset Turnover Ratio (%) | 2.24 | 2.47 | 3.02 | 2.60 | 2.05 |
| Current Ratio (X) | 0.79 | 0.76 | 0.78 | 1.03 | 0.86 |
| Quick Ratio (X) | 0.63 | 0.57 | 0.61 | 0.71 | 0.65 |
| Inventory Turnover Ratio (X) | 27.08 | 31.12 | 22.01 | 16.85 | 17.83 |
| Dividend Payout Ratio (NP) (%) | 15.36 | 17.54 | 11.65 | 13.17 | 32.66 |
| Dividend Payout Ratio (CP) (%) | 8.52 | 8.96 | 6.50 | 5.31 | 6.88 |
| Earning Retention Ratio (%) | 84.64 | 82.46 | 88.35 | 86.83 | 67.34 |
| Cash Earning Retention Ratio (%) | 91.48 | 91.04 | 93.50 | 94.69 | 93.12 |
| Interest Coverage Ratio (X) | 8.87 | 8.44 | 13.85 | 9.59 | 6.76 |
| Interest Coverage Ratio (Post Tax) (X) | 4.67 | 4.24 | 6.93 | 4.05 | 2.12 |
| Enterprise Value (Cr.) | 559.24 | 538.61 | 313.58 | 245.72 | 222.69 |
| EV / Net Operating Revenue (X) | 0.43 | 0.50 | 0.29 | 0.30 | 0.40 |
| EV / EBITDA (X) | 7.08 | 8.24 | 6.23 | 6.56 | 7.71 |
| MarketCap / Net Operating Revenue (X) | 0.37 | 0.42 | 0.24 | 0.25 | 0.35 |
| Retention Ratios (%) | 84.63 | 82.45 | 88.34 | 86.82 | 67.33 |
| Price / BV (X) | 2.48 | 2.70 | 1.74 | 1.65 | 1.67 |
| Price / Net Operating Revenue (X) | 0.37 | 0.42 | 0.24 | 0.25 | 0.35 |
| EarningsYield | 0.06 | 0.05 | 0.08 | 0.05 | 0.02 |
After reviewing the key financial ratios for Bharat Seats Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.21. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 5.21, marking a decrease of 2.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.21. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 5.21, marking a decrease of 2.77.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.39. This value is within the healthy range. It has decreased from 15.62 (Mar 24) to 9.39, marking a decrease of 6.23.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.98. It has decreased from 53.13 (Mar 24) to 30.98, marking a decrease of 22.15.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 30.98. It has decreased from 53.13 (Mar 24) to 30.98, marking a decrease of 22.15.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.10. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.10, marking a decrease of 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 205.23. It has decreased from 339.75 (Mar 24) to 205.23, marking a decrease of 134.52.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.59. This value is within the healthy range. It has decreased from 20.80 (Mar 24) to 12.59, marking a decrease of 8.21.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.41. This value is within the healthy range. It has decreased from 13.16 (Mar 24) to 8.41, marking a decrease of 4.75.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.99. This value is within the healthy range. It has decreased from 10.69 (Mar 24) to 6.99, marking a decrease of 3.70.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.21. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 5.21, marking a decrease of 2.77.
- For PBDIT Margin (%), as of Mar 25, the value is 6.13. This value is below the healthy minimum of 10. It has increased from 6.12 (Mar 24) to 6.13, marking an increase of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 4.09. This value is below the healthy minimum of 10. It has increased from 3.87 (Mar 24) to 4.09, marking an increase of 0.22.
- For PBT Margin (%), as of Mar 25, the value is 3.40. This value is below the healthy minimum of 10. It has increased from 3.14 (Mar 24) to 3.40, marking an increase of 0.26.
- For Net Profit Margin (%), as of Mar 25, the value is 2.53. This value is below the healthy minimum of 5. It has increased from 2.34 (Mar 24) to 2.53, marking an increase of 0.19.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.80. This value is within the healthy range. It has increased from 15.01 (Mar 24) to 16.80, marking an increase of 1.79.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.54. This value is within the healthy range. It has increased from 14.13 (Mar 24) to 16.54, marking an increase of 2.41.
- For Return On Assets (%), as of Mar 25, the value is 5.04. This value is within the healthy range. It has increased from 4.95 (Mar 24) to 5.04, marking an increase of 0.09.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has decreased from 0.31 (Mar 24) to 0.25, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.41. This value is within the healthy range. It has decreased from 0.52 (Mar 24) to 0.41, marking a decrease of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.24. It has decreased from 2.47 (Mar 24) to 2.24, marking a decrease of 0.23.
- For Current Ratio (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1.5. It has increased from 0.76 (Mar 24) to 0.79, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.63, marking an increase of 0.06.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 27.08. This value exceeds the healthy maximum of 8. It has decreased from 31.12 (Mar 24) to 27.08, marking a decrease of 4.04.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.36. This value is below the healthy minimum of 20. It has decreased from 17.54 (Mar 24) to 15.36, marking a decrease of 2.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 8.52. This value is below the healthy minimum of 20. It has decreased from 8.96 (Mar 24) to 8.52, marking a decrease of 0.44.
- For Earning Retention Ratio (%), as of Mar 25, the value is 84.64. This value exceeds the healthy maximum of 70. It has increased from 82.46 (Mar 24) to 84.64, marking an increase of 2.18.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 91.48. This value exceeds the healthy maximum of 70. It has increased from 91.04 (Mar 24) to 91.48, marking an increase of 0.44.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.87. This value is within the healthy range. It has increased from 8.44 (Mar 24) to 8.87, marking an increase of 0.43.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.67. This value is within the healthy range. It has increased from 4.24 (Mar 24) to 4.67, marking an increase of 0.43.
- For Enterprise Value (Cr.), as of Mar 25, the value is 559.24. It has increased from 538.61 (Mar 24) to 559.24, marking an increase of 20.63.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.43, marking a decrease of 0.07.
- For EV / EBITDA (X), as of Mar 25, the value is 7.08. This value is within the healthy range. It has decreased from 8.24 (Mar 24) to 7.08, marking a decrease of 1.16.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.37, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 84.63. This value exceeds the healthy maximum of 70. It has increased from 82.45 (Mar 24) to 84.63, marking an increase of 2.18.
- For Price / BV (X), as of Mar 25, the value is 2.48. This value is within the healthy range. It has decreased from 2.70 (Mar 24) to 2.48, marking a decrease of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 0.42 (Mar 24) to 0.37, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.06, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bharat Seats Ltd:
- Net Profit Margin: 2.53%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.54% (Industry Average ROCE: 15.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.8% (Industry Average ROE: 122.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.67
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.6 (Industry average Stock P/E: 37.79)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.41
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.53%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Others | 1, Nelson Mandela Road, New Delhi Delhi 110070 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Rohit Relan | Chairman & Managing Director |
| Mr. Rajiv Arora | WholeTime Director & CEO |
| Mr. Rishabh Relan | Whole Time Director |
| Mr. Sanjay Bhattacharyya | Independent Director |
| Mr. Sudhir Maheshwari | Independent Director |
| Ms. Nisha Malhotra | Independent Director |
| Ms. Vanita Chhabra | Independent Director |
| Mr. Sarthak Behuria | Independent Director |
| Mr. Raman Venkat Challa | Nominee Director |
| Mr. Makoto Kunieda | Nominee Director |
FAQ
What is the intrinsic value of Bharat Seats Ltd?
Bharat Seats Ltd's intrinsic value (as of 21 January 2026) is ₹142.09 which is 0.64% lower the current market price of ₹143.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹900 Cr. market cap, FY2025-2026 high/low of ₹240/61.1, reserves of ₹194 Cr, and liabilities of ₹693 Cr.
What is the Market Cap of Bharat Seats Ltd?
The Market Cap of Bharat Seats Ltd is 900 Cr..
What is the current Stock Price of Bharat Seats Ltd as on 21 January 2026?
The current stock price of Bharat Seats Ltd as on 21 January 2026 is ₹143.
What is the High / Low of Bharat Seats Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bharat Seats Ltd stocks is ₹240/61.1.
What is the Stock P/E of Bharat Seats Ltd?
The Stock P/E of Bharat Seats Ltd is 23.6.
What is the Book Value of Bharat Seats Ltd?
The Book Value of Bharat Seats Ltd is 32.9.
What is the Dividend Yield of Bharat Seats Ltd?
The Dividend Yield of Bharat Seats Ltd is 0.77 %.
What is the ROCE of Bharat Seats Ltd?
The ROCE of Bharat Seats Ltd is 15.6 %.
What is the ROE of Bharat Seats Ltd?
The ROE of Bharat Seats Ltd is 18.0 %.
What is the Face Value of Bharat Seats Ltd?
The Face Value of Bharat Seats Ltd is 2.00.